Emerging Technology

Precision for Medicine partners with Agena Bioscience to fill NGS testing gaps

By LabPulse.com staff writers

Partnership addresses insufficient sample quality in next-generation sequencing (NGS) testing.

November 20, 2024

Roche gets CE Mark for ovarian cancer CDx test

By LabPulse.com staff writers

Roche has received the CE Mark under the European Union's In Vitro Diagnostic Regulation for its companion diagnostic (CDx) test, which is designed to aid in identifying ovarian cancer patients eligible for targeted treatment with Abbvie's Elahere.

November 19, 2024

Lunit adds AstraZeneca for NSCLC biomarker screening AI

By LabPulse.com staff writers

Companies to integrate Scope Genotype Predictor into pathology workflows to screen for actionable mutations in non-small cell lung cancer research.

November 18, 2024

Flatiron to offer Tempus AI's testing through OncoEMR platform

By LabPulse.com staff writers

Flatiron Health will incorporate comprehensive genetic testing from precision medicine firm Tempus AI directly into its cloud-based electronic medical record (EMR) platform.

November 13, 2024

Sunbird Bio shares new data on blood-based Parkinson's diagnostic

By LabPulse.com staff writers

Biotech firm Sunbird Bio announced new data from a study demonstrating that Sunbird's technology could provide blood-based diagnosis of Parkinson's disease and other neurodegenerative diseases with a high level of accuracy.

November 1, 2024

Caris Life Sciences gets FDA approval for CDx

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Caris Life Sciences' MI Cancer Seek for use as a companion diagnostic (CDx) to identify cancer patients who may benefit from targeted treatments.

November 6, 2024

Alzheimer's panel validated in University of Pittsburgh study

By LabPulse.com staff writers

A team at the University of Pittsburgh has validated a new blood test panel that can simultaneously measure over 100 Alzheimer's disease biomarkers.

November 4, 2024

Molecular You partners with Calif. reference lab for biomarker testing

By LabPulse.com staff writers

Multiomic test developer Molecular You and reference laboratory HealthQuest Esoterics have partnered to expand predictive biomarker testing to healthcare clinics across the U.S.

October 21, 2024

Flatiron, Myriad partner to integrate cancer test with EMR platform

By LabPulse.com staff writers

Myriad Genetics and Flatiron Health are partnering to integrate Myriad's MyRisk Hereditary Cancer Test into Flatiron's cloud-based OncoEMR electronic medical record (EMR) platform.

October 15, 2024

FDA approves Genentech's breast cancer therapy, Foundation Medicine's CDx

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) approved the FoundationOne Liquid test as a companion diagnostic (CDx) with Genentech's Itovebi combination therapy for certain patients with HR-positive, HER2-negative advanced or metastatic breast cancer.

October 14, 2024

MiLaboratories raises $10M in series A funding, launches NGS software platform

By LabPulse.com staff writers

Bioinformatics firm MiLaboratories closed a $10 million series A funding round alongside the launch of its Platforma.bio Software Development Kit.

October 11, 2024

FDA greenlights first non-EUA at-home flu and COVID-19 test

By LabPulse.com staff writers

Healgen Scientific's test targets proteins from both SARS-CoV-2 and flu A and B, plus updated FDA test listings.

October 8, 2024

Page 1 of 54

Next Page